Millie Das Selected Research

Millie Das Research Topics

Disease

13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2011
11	Neoplasms (Cancer) 11/2022 - 09/2011
6	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2010
2	Neoplasm Metastasis (Metastasis) 11/2022 - 02/2013
2	Disease Progression 01/2022 - 10/2020
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2020 - 01/2020
1	Malignant Pleural Effusion 11/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Heart Failure 12/2021
1	Supraventricular Tachycardia 12/2021
1	Cardiotoxicity 12/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2020
1	Neuroendocrine Carcinoma 04/2020
1	Dizziness (Lightheadedness) 04/2020
1	Confusion (Bewilderment) 04/2020
1	Sleepiness 04/2020
1	Fatigue 01/2018
1	Nausea 01/2018
1	Exanthema (Rash) 01/2018
1	Diarrhea 01/2018
1	Adenocarcinoma of Lung 01/2017
1	Circulating Neoplastic Cells 08/2012

Drug/Important Bio-Agent (IBA)

4	PlatinumIBA 01/2022 - 08/2012
4	Pharmaceutical PreparationsIBA 11/2021 - 09/2015
3	Bevacizumab (Avastin)FDA Link 01/2022 - 04/2012
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2018
2	osimertinibIBA 01/2022 - 12/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2021 - 09/2015
2	Circulating Tumor DNAIBA 01/2021 - 01/2020
2	B7-H1 AntigenIBA 01/2021 - 01/2020
2	Docetaxel (Taxotere)FDA Link 12/2014 - 09/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 04/2012
2	Monoclonal AntibodiesIBA 12/2014 - 04/2012
2	Pemetrexed (MTA)FDA Link 09/2013 - 02/2013
1	Ado-Trastuzumab EmtansineIBA 01/2022
1	trastuzumab deruxtecanIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	dabrafenibIBA 12/2021
1	brigatinibIBA 12/2021
1	trametinibIBA 12/2021
1	lorlatinibIBA 12/2021
1	alectinibIBA 12/2021
1	ceritinibIBA 12/2021
1	Gefitinib (Iressa)FDA Link 12/2021
1	CrizotinibIBA 12/2021
1	AfatinibIBA 12/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021
1	PM 01183IBA 11/2021
1	durvalumabIBA 01/2021
1	GlutaminaseIBA 12/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 04/2020
1	Desipramine (Pertofrane)FDA LinkGeneric 04/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	atezolizumabIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	XL647IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 09/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2014
1	RamucirumabIBA 12/2014
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	motesanib diphosphateIBA 12/2012
1	Carboplatin (JM8)FDA LinkGeneric 09/2011

Therapy/Procedure

10	Therapeutics 11/2022 - 09/2013
6	Drug Therapy (Chemotherapy) 01/2022 - 08/2012
3	Immunotherapy 01/2022 - 01/2020
2	Radiotherapy 09/2011 - 06/2010
1	Time-to-Treatment 01/2022
1	Precision Medicine 01/2021
1	Chemoradiotherapy 09/2011
1	Radiofrequency Ablation 06/2010